Democrats see drugmaker windfall from Medicare
WASHINGTON (Reuters) - U.S. pharmaceutical companies benefited from a $3.7 billion "windfall" during the first two years of Medicare's prescription drug coverage, according to a report from Democratic congressional staff released on Thursday.
<p>You are not allowed to view links.
Register or
Login![](http://feeds.feedburner.com/~a/reuters/healthNews?i=zRupue" border="0)
</img>
</p><div class="feedflare">
You are not allowed to view links.
Register or
Login![](http://feeds.feedburner.com/~f/reuters/healthNews?i=VbH3vJ" border="0)
</img>
You are not allowed to view links.
Register or
Login![](http://feeds.feedburner.com/~f/reuters/healthNews?i=O0k0Pj" border="0)
</img>
You are not allowed to view links.
Register or
Login![](http://feeds.feedburner.com/~f/reuters/healthNews?i=DEUoFj" border="0)
</img>
</div>
![](http://feeds.feedburner.com/~r/reuters/healthNews/~4/345006035" height="1" width="1)
You are not allowed to view links.
Register or
Login
